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Abstract
This case report describes about a young, male patient with persisting syncope during physical
therapy for complex regional pain syndrome type 1 after metatarsal fractures.
The patient was referred to the Emergency Department, where Brugada syndrome was diagnosed.
A cardioverter defibrillator was prophylactically implanted successfully. After this procedure, there
were no contraindications for resuming further physical therapy for his painful foot. No clear causal
inference with Brugada could be drawn from the complex regional pain syndrome type 1 or physical
therapy described in this case report. Hyperthermia may, however, occur during such therapy,
which is associated with dysrhythmia in general.
Case presentation
Background
Brugada syndrome is an autosomal dominant disease that
can cause syncope and sudden cardiac death in young
individuals with a normal heart [1].
It is characterized by an electrocardiographic pattern of
complete or incomplete right bundle branch block and ST
segment elevation in leads V1–V3. Around 20–25% of
patients affected by this syndrome have genetic mutations
in SCN5A, which cause a functional reduction in the avail-
ability of the cardiac sodium current in Brugada syn-
drome. The relative male preponderance of the
phenotype, despite equal inheritance of the gene in males
and females, has led to the speculation of a role for testo-
sterone in the phenotype [2,3]. The disease may manifest
first as cardiac arrest without any previous symptoms. The
electrocardiographic pattern may be intermittent, requir-
ing a pharmacological challenge with Class I anti-dys-
rhythmic drugs like flecainide to unmask the ST elevation.
Dysrhythmias and sudden death generally occur during
sleep or rest, but features of ECGs from Brugada patients
also illustrate a cardiac sodium channel mutation. The
arhythmogenicity characteristic of this mutation is
revealed only at temperatures approaching the physiolog-
ical range, and this suggests that some patients may be at
greater risk during hyperthermia [4].
According to the International Association for the Study
of Pain (IASP) in 1994, reflex sympathetic dystrophy and
its many synonyms are collectively referred to as Complex
Regional Pain Syndrome (CRPS). Two types can be distin-
guished: CRPS-1 may occur in an extremity after even a
minor injury or operation, and CRPS-2 may occur only
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when nerve injury is involved. In the acute phase, signs
and symptoms of inflammation or ischemia within the
affected extremity characterize CRPS. Although the clini-
cal signs and symptoms of CRPS are well known, the
underlying pathophysiology remains unclear despite the
knowledge that disuse precedes CRPS in most cases. Many
clinicians use the Bruehl criteria to make a proper diagno-
sis, in which continuing pain disproportionate to the pro-
vocative event is the most frequent symptom [5]. Sensory,
vasomotor, or sudomotor changes with edema, combined
with a decreased range of motion with motor dysfunction
and trophic changes, must also be present for diagnosing
CRPS-1.
An accepted portion of the treatment consists of pain-con-
tingent physical therapy to regain function and strength in
the affected limb [6]. Pain Exposure Physical Therapy
(PEP-therapy) is a different approach, in which functional
physical therapy is combined with a cognitive – behavio-
ral form of treatment for patients who are well-motivated
to achieve functional targets. They are invited to use an
active coping style to realize the treatment goal during five
sessions spanning three months, and they are evaluated
three months after the last session (time contingent). For
this type of therapy, the use of analgesics, splints, and
crutches is reduced. Additionally, treatment does not
focus on the existing pain, and patients are instructed that
pain should not be interpreted as a signal of tissue dam-
age. This process disrupts the vicious circle of fear of
movement, pain avoidance, and dysregulation of the sym-
pathetic and central nervous system. Touching and mov-
ing the extremity decreases the fear of movement and
increases the extremity's mobility. Clear treatment plans
and empathic communication, as well as stimulation and
positive feedback, are part of the standard plan. The
patient is encouraged to attempt to achieve a realistic
treatment goal for the next session by practicing the exer-
cises at home. This approach has been shown to be suc-
cessful in children [7]. No evidence has been provided yet
for treating adult patients with CRPS-1 in this way, but we
have been successfully treating patients with therapy-
resistant CRPS-1 since 2005. A first report describing our
results is in preparation.
The purpose of this case report is to describe a patient in
whom Brugada syndrome was unmasked during PEP-
therapy for CRPS-1 after metatarsal fractures. This report
is intended to increase the awareness of healthcare work-
ers, and to help recognizing the risk of strenuous physical
therapy in such patients. Hypothetical causal inference
should, however, always be interpreted with caution. An
association of CRPS-1 with Brugada syndrome has never
been reported. It is therefore more likely to assume a rela-
tionship with this patient's active physical therapy
involvement during the presentation of his symptoms.
Patient History
A 41-year old, slender, Caucasian male was referred to our
outpatient department two years after having sustained
midshaft fractures of the second and third metatarsal
bone due to the crash of a heavy tent-pole. Both fractures
were successfully treated non-operatively. The pain in his
foot, however, did not resolve with normal physical ther-
apy, and six months after the accident he presented with
symptoms of a CRPS-1 according to the criteria of Bruehl
[5]. He was referred to our hospital's department of phys-
ical therapy to undergo PEP-therapy in order to regain
function of the lower extremity and be able to walk with-
out restrictions.
He was otherwise healthy, and no co-morbidities or con-
tra-indications were reported. He was not known with
tobacco, drugs or alcohol abuse.
Examination
This patient was seen in the department of physical ther-
apy for his first treatment. Earlier treatment with pain con-
tingent physical therapy, manual therapy, acupuncture,
and action potential stimulation (APS) therapy had
resulted in independent gait with orthopaedic shoes that
were adapted to relieve his forefoot. The only pain medi-
cation he used was paracetamol. Pain relief and improve-
ment of walking ability were the main reasons for which
he sought treatment.
Physical examination showed a healthy, slender white
male with a height of 193 cm and a weight of 80 kgs with-
out further abnormalities. He presented with symptoms
of allodynia, hyperesthesia, vasomotor, sudomotor and
trophic changes, a decrease in the active and passive range
of motion for the right ankle and toes, dystonia during
foot extension, and a burning sensation during walking.
He avoided placing any weight bearing on his forefoot
and presented a passive way of walking.
After the painful examination, he was well motivated to
begin treatment. His allodynia was treated with resump-
tion of passive mobility during the first visit.
Treatment
The means provided in Pain Exposure Physical therapy
(PEP-therapy) are articular movement, including traction,
translation, manipulation, massage, desensitization,
flooding (experience of the most fearful action), muscle
lengthening, and guiding. Exercising of the normal move-
ment patterns (functional training) with posture and
relaxation exercises in front of a mirror accompany
instructions, information, and advice. The patient is
taught to experience the sensation of pain as non-func-
tional and practice the exercises at home. Because pain
experience is rational and rational attention is redirectedCases Journal 2008, 1:107 http://www.casesjournal.com/content/1/1/107
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from pain behavior to the ability to move, the patient's
pain behavior will decrease as his self-confidence in his
physical abilities increases. This progress is encouraged by
positive feedback from two therapists and the patient's
partner.
Touching and massaging the painful foot was initiated
with the explanation that the pain sensation is not harm-
ful. The dystonic extensors of the foot were stretched, and
the patient was instructed to do so himself. Touching and
stretching caused a strong pain perception, which the
patient expressed via facial grimaces and tightening of his
muscles.
At the end of this first foot and ankle treatment session,
the patient suddenly blacked out, recovered spontane-
ously, and began hyperventilating. According to his
accompanying wife, these symptoms were common for
him and hyperventilation had already occurred several
years earlier. Because no one had asked, the patient had
not mentioned this fact before. This time, however, the
patient was still uneasy after an hour of relaxation and
breath control exercises. The physical therapist advised
him to attend the hospital's Emergency Ward to further
evaluate hyperventilation with syncope [8].
Outcome
This patient presented at the Emergency Ward with symp-
toms of blurred vision, tingling hands, and numbness of
the right cheek. He had shown incidental hyperventila-
tion throughout the last fifteen years. In one instance, he
had collapsed when such an episode occurred while he
was gardening. Cardiologic evaluation did not reveal any
abnormalities at that time. He mentioned a recent sudden
collapse in the shower with rapid spontaneous recovery
without premonitory symptoms. He denied any other
specific (cardiac) complaints such as chest pain, palpita-
tions, or dyspnoea. His medical history was otherwise
uneventful except for an inguinal hernia repair during
childhood. A family history notes that his father survived
a myocardial infarction at the age of fifty years. His frater-
nal twin brother had fully recovered from epilepsy during
his early childhood. One younger brother died shortly
after birth from severe spina bifida.
Electrocardiography showed a Brugada-like pattern with
typical ST segment elevation in the right precordial leads,
which has been designated as type II Brugada (fig. 1) [9].
He was admitted for further evaluation. A flecainide prov-
ocation test was positive, with a shift from type II to type
I, accompanied by symptoms of syncope (fig. 2). Provoca-
tion during an electrophysiological study with pacing of
the right ventricle produced a ventricular flutter with rec-
Electrocardiography at first presentation Figure 1
Electrocardiography at first presentation. Electrocardiography at first presentation with a high take-off ST segment ele-
vation with upward concavity and positive or biphasic T-wave resulting in a saddleback configuration.Cases Journal 2008, 1:107 http://www.casesjournal.com/content/1/1/107
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ognizable symptoms of syncope, which lasted seven sec-
onds and terminated spontaneously (fig. 3). An
automated implantable cardioverter defibrillator (AICD)
was prophylactically implanted, and the patient's twin
brother was advised to undergo screening.
Although no contraindications existed for resumption of
the physical therapy according to recent guidelines, the
patient preferred to accept the current condition of his
painful foot [10].
Discussion
Strenuous physical therapy may evoke a variety of invol-
untary patient reactions like hyperventilation. When
patients are hyperventilating and do not recover sponta-
neously or respond to common treatment strategies like
paper bag rebreathing, syncope may occur. Any syncope
requires thorough clinical evaluation to exclude serious
disorders like cardiac arrhythmia and epilepsy [8].
Brugada syndrome is a rare cardiac arrhythmia that may
cause syncope in otherwise healthy young people. Several
conditions producing Brugada-like electrocardiographic
patterns, like the 'long QT syndrome,' should be borne in
mind and excluded while making a diagnosis of the Bru-
gada syndrome [1]. Treatment of patients suffering from
Brugada is difficult, because pharmacological agents are
not universally effective. State-of-the-art management
involves the implantation of a cardioverter defibrillator.
Additionally, symptomatic patients with inducible ven-
tricular dysrhythmias and a positive family history, like
the patient described in this report, should be considered
for prophylactic implantation of a cardioverter defibrilla-
tor. This patient had a history of hyperventilation, which
could have been a symptom of masked Brugada. How-
ever, hyperventilation may also be the cause of syncope.
In addition, this may cause variant angina, which may in
turn induce ischemic, life-threatening dysrhythmia. Our
patient underwent painful PEP-therapy, which can be
considered as strenuous exercise. Strenuous activities and
sudden death have also lead to the identification of Bru-
gada syndrome in athletes [1]. It has been assumed that
strenuous exercise and its resultant increase in body core
temperature can unmask the Brugada syndrome. This
could have occurred during PEP-therapy for CRPS-1 in
our patient [4].
The patient did not mention any form of hyperventilation
during our first contact. Due to the presence of his wife, he
remembered his history of hyperventilation and syncope
during the treatment session. No association between
Brugada syndrome and any form of physical therapy or
Electrocardiography after provocation with flecainide Figure 2
Electrocardiography after provocation with flecainide. Electrocardiography after provocation with flecainide with a 
shift from type II to type I.Cases Journal 2008, 1:107 http://www.casesjournal.com/content/1/1/107
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CRPS-1 has ever been described. Therefore, any unex-
pected symptoms of syncope during strenuous or painful
treatments deserve further evaluation to prevent sudden
death and must be interpreted as a "red flag" or serious
warning sign. Most physical therapists are adequately
equipped with professional knowledge to detect these
warning signs in patients undergoing treatments, such as
the case demonstrated in this case report.
Conclusion
Strenuous physical therapy may evoke a variety of invol-
untary patient reactions like hyperventilation. When
patients are hyperventilating and do not recover sponta-
neously or respond to common treatment strategies like
paper bag rebreathing, syncope may occur. Any symptoms
of syncope during strenuous treatment or exercise deserve
further evaluation to prevent sudden death.
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